摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-decyl-4-(hydroxymethyl)-3-methyl-1H-1,2,3-triazol-3-ium acetate

中文名称
——
中文别名
——
英文名称
1-decyl-4-(hydroxymethyl)-3-methyl-1H-1,2,3-triazol-3-ium acetate
英文别名
(1-Decyl-3-methyltriazol-1-ium-4-yl)methanol;acetate;(1-decyl-3-methyltriazol-1-ium-4-yl)methanol;acetate
1-decyl-4-(hydroxymethyl)-3-methyl-1H-1,2,3-triazol-3-ium acetate化学式
CAS
——
化学式
C2H3O2*C14H28N3O
mdl
——
分子量
313.44
InChiKey
AVVMIZZEUFKWRA-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    22
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    82.1
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    1-叠氮癸烷copper(ll) sulfate pentahydratesodium ascorbate 、 sodium hydroxide 作用下, 以 乙醇乙腈 为溶剂, 反应 216.0h, 生成 1-decyl-4-(hydroxymethyl)-3-methyl-1H-1,2,3-triazol-3-ium acetate
    参考文献:
    名称:
    用于高效 CO2 转化的单组分、无金属、无溶剂 H2O 官能化 1,2,3-三唑基离子液体催化剂
    摘要:
    一系列带有不同烷基链和反阴离子的 H2O 功能化 1,2,3-三唑离子液体 ( 1-9b ) 被评估为绿色、单组分、双功能催化剂,用于涉及 CO 2和环氧化物的环加成反应。它们是使用廉价、无毒和广泛可用的起始材料通过清洁、简便和高产率的三步程序制备的。化合物1-9b通过光谱技术进行了表征, 3b的分子结构也通过单晶X射线衍射。催化结果证明羟基和抗衡阴离子之间的协同作用对于实现出色的周转频率 (TOF) 至关重要。平行地,中性三唑在相同反应条件下表现出非常低的活性。使用最佳反应条件(25 mmol 环氧化物、140 °C、30 bar CO 2和 1 小时),实现了所有末端环氧化物的高转化率,包括在产生 667 小时出色 TOF 值的放大实验中-1。此外,使用氧化环己烯的反应仅在 6 小时内就实现了 85% 的转化率。总之,我们的结果显示了 H2O 功能化 1,2,3-三唑基离子液体催化剂对高效
    DOI:
    10.1039/d2nj02052a
点击查看最新优质反应信息

文献信息

  • 1,2,3-Triazole derivatives: synthesis, docking, cytotoxicity analysis and in vivo antimalarial activity
    作者:Fernanda Valério Lopes、Pedro Henrique Fazza Stroppa、Juliane Aparecida Marinho、Roberta Reis Soares、Lara de Azevedo Alves、Priscila Vanessa Zabala Capriles Goliatt、Clarice Abramo、Adilson David da Silva
    DOI:10.1016/j.cbi.2021.109688
    日期:2021.12
    presented by chloroquine; the most common antimalarial drug. Cytotoxicity and hemolysis by these derivatives were evaluated in vitro. The compounds 1, 2, 5, 8, and 9 proved to be non-cytotoxic in the performed tests. In vivo antimalarial activity was evaluated using mice infected with Plasmodium berghei NK65. The five compounds tested exhibited antimalarial activity until nine days post-infection. The compound
    疟疾仍然是世界上最重要的寄生虫病之一。多重耐药疟原虫菌株使目前可用于疟疾的治疗效果较差。因此,必须开发新药来克服治疗耐药性。三唑衍生物表现出多种生物活性,并提供了一个从生物学角度看有前途的部分。由于与 NADH 的结构相似,人们认为三唑类化合物可以与乳酸疟原虫脱氢酶 (pLDH)的活性位点结合。目前的工作通过计算机、体外和体内研究评估了 1,2,3-三唑衍生物的抗疟活性。初步的对化合物的计算机模拟 ADMET 研究显示出良好的药代动力学特性。对伯氏疟原虫(Pb LDH)LDH的电子对接分析表明,所有化合物都与活性位点的催化残基相互作用,亲和力与氯喹相似;最常见的抗疟药。体外评估了这些衍生物的细胞毒性和溶血作用。化合物1,2,5,8,和9被证明是在执行的测试的非细胞毒性的。体内抗疟活性使用感染了伯氏疟原虫NK65。测试的五种化合物在感染后 9 天都表现出抗疟活性。化合物5显示出有希望的活性,抑制了约
  • Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis
    作者:Pedro H.F. Stroppa、Luciana M.R. Antinarelli、Arturene M.L. Carmo、Jacy Gameiro、Elaine S. Coimbra、Adilson D. da Silva
    DOI:10.1016/j.bmc.2017.03.051
    日期:2017.6
    Here, we report the effect of new non-classical bioisosteres of miltefosine on Leishmania amazonensis. Fifteen compounds were synthesized and the compound dhmtAc, containing an acetate anion, a side chain of 10 carbon atoms linked to N-1 and a methyl group linked to N-3, showed high and selective biological activity against L. amazonensis. On the intracellular amastigotes, stages of the parasite related to human disease, the IC50 values were near or similar to the 1.0 mu M (0.9, 0.8 and 1.0 mu M on L. amazonensis-WT, and two transgenic L. amazonensis expressing GFP and RFP, respectively), being more active than miltefosine. Furthermore, dhmtAc did not show toxic effects on human erythrocytes and macrophages (CC50 = 115.91 mu M) being more destructive to the intracellular parasites (selectivity index > 115). Promastigotes and intramacrophage amastigotes treated with dhmtAc showed low capacity for reversion of the effect of the compound. A study of the mechanism of action of this compound showed some features of metazoan apoptosis, including cell volume decreases, loss of mitochondrial membrane potential, ROS production, an increase in the intracellular lipid bodies, in situ labeling of DNA fragments by TUNEL labeling and phosphatidylserine exposure to the outerleaflet of the plasma membrane. In addition, the plasma membrane disruption, revealed by PI labeling, suggests cell death by necrosis. No increase in autophagic vacuoles formation in treated promastigotes was observed. Taken together, the data indicate that the bioisostere of miltefosine, dhmtAc, has promising antileishmanial activity that is mediated via apoptosis and necrosis. (C) 2017 Elsevier Ltd. All rights reserved.
  • Correlation of structural features of novel 1,2,3-triazoles with their neurotoxic and tumoricidal properties
    作者:Elaine Maria de Souza-Fagundes、Johannes Delp、PedroH.D.M. Prazeres、Lucas Bonfim Marques、Arturene Maria Lino Carmo、Pedro Henrique Fazza Stroppa、Nicolas Glanzmann、Jaffar Kisitu、Dàvid Szamosvàri、Thomas Böttcher、Marcel Leist、Adilson David da Silva
    DOI:10.1016/j.cbi.2018.06.029
    日期:2018.8
    Triazoles are interesting templates for novel chemotherapeutic drugs. We synthesized here 17 1,3,4-substituted-1,2,3-triazoles that differed in their l'-substituent (variable alkyl chain lengths C3-C12), the 3'-substituent (no substituent, -methyl or -propyl) or the salt form obtained. Several of the compounds were cytotoxic (mu M range) for tumor cells (HL-60, Jurkat, MCF-7, HCT-116), and when the effect was compared to non-transformed cells (Vero), selectivity ratios of up to 23-fold were obtained. To estimate the liability of these potential drug candidates for triggering neurotoxicity, we used the LUHMES cell-based NeuriTox assay. This test quantifies damage to the neurites of human neurons. The four most potent tumoricidal compounds were found to be neurotoxic in a concentration range similar to the one showing tumor cell toxicity. As the neurites of the LUHMES neurons were affected at > 4-fold lower concentrations than the overall cell viability, the novel triazoles were classified as specific neurotoxicants. The structure-activity relationship (SAR) for neurotoxicity was sharply defined and correlated with the one for anti-neoplastic activity. Based on this SAR, two non-neurotoxic compounds were predicted, and testing in the NeuriTox assay confirmed this prediction. In summary, the panel of novel triazoles generated and characterized here, allowed to define structural features associated with cytotoxicity and neurotoxicity. Moreover, the study shows that potential neurotoxic side effects may be predicted early in drug development if highly sensitive test methods for neurite integrity are applied.
  • Single-component, metal-free, solvent-free HO-functionalized 1,2,3-triazole-based ionic liquid catalysts for efficient CO<sub>2</sub> conversion
    作者:Álvaro Farias Arruda da Mata、Nicolas Glanzmann、Pedro Henrique Fazza Stroppa、Felipe Terra Martins、Rafael Pavão das Chagas、Adilson David da Silva、Jorge Luiz Sônego Milani
    DOI:10.1039/d2nj02052a
    日期:——
    CO2, and 1 h), high conversion of all terminal epoxides was achieved, including in a scale-up experiment that produced an outstanding TOF value of 667 h−1. Moreover, a reaction using cyclohexene oxide achieved 85% conversion in only 6 h. In summary, our results show the attractive potential of HO-functionalized 1,2,3-triazole-based ionic liquid catalysts for efficient CO2 conversion to cyclic carbonates
    一系列带有不同烷基链和反阴离子的 H2O 功能化 1,2,3-三唑离子液体 ( 1-9b ) 被评估为绿色、单组分、双功能催化剂,用于涉及 CO 2和环氧化物的环加成反应。它们是使用廉价、无毒和广泛可用的起始材料通过清洁、简便和高产率的三步程序制备的。化合物1-9b通过光谱技术进行了表征, 3b的分子结构也通过单晶X射线衍射。催化结果证明羟基和抗衡阴离子之间的协同作用对于实现出色的周转频率 (TOF) 至关重要。平行地,中性三唑在相同反应条件下表现出非常低的活性。使用最佳反应条件(25 mmol 环氧化物、140 °C、30 bar CO 2和 1 小时),实现了所有末端环氧化物的高转化率,包括在产生 667 小时出色 TOF 值的放大实验中-1。此外,使用氧化环己烯的反应仅在 6 小时内就实现了 85% 的转化率。总之,我们的结果显示了 H2O 功能化 1,2,3-三唑基离子液体催化剂对高效
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺